Yu Kehao, Song Wentao, Tu Xinyu, Zhou Ke, Prabahar Kousalya
Medical College of PanZhiHua University, PanZhiHua University, NO.10, Jichang Road, East District, Panzhihua, Sichuan 617000, China.
Medical College of Southwest Medical University, No.319, Section 3, Zhongshan Road, Jiangyang District, Luzhou, Sichuan 646000, China.
Prostaglandins Other Lipid Mediat. 2025 Jan;176:106938. doi: 10.1016/j.prostaglandins.2024.106938. Epub 2024 Dec 10.
Previous studies have reported on the relationship between vitamin D and the lipid profile in individuals with obesity or overweight, but results have been inconsistent. Hence, we conducted this meta-analysis and systematic review of randomized controlled trials to assess the effect of vitamin D on the lipid profile in individuals with overweight or obesity.
A meticulous search strategy was used in various databases, and article published up to November 2023 were included. The DerSimonian and Laird random effects model was applied to compute the weighted mean difference (WMD) and 95 % confidence intervals (CI) of the intervention on each variable.
Vitamin D supplementation did not yield significant alterations in LDL-C (WMD: 2.10 mg/dL, CI: -5.20-9.41, p = 0.572), HDL-C (WMD: 1.49 mg/dL, 95 % CI: -1.55-4.55, P = 0.337), and TC concentrations (WMD: -1.99 mg/dL, CI: -8.21-4.22, P = 0.530). Conversely, a significant decrease in TG levels was observed studies conducted in individuals with comorbidities (WMD: -6.03 mg/dL, 95 % CI: -11.92 to -0.15, p = 0.044), vitamin D doses of ≥ 50000 IU/week (WMD: -20.87 mg/dL, 95 % CI: -39.63 to -2.11, P = 0.029), and subjects with baseline TG concentrations ≥ 150 mg/dl (WMD: -25.95 mg/dL, 95 % CI: -51.51 to -0.40, p = 0.046).
According to our study findings, vitamin D has significant effect on the hypertriglyceridemia in individuals with obesity or overweight. However, vitamin D has no significant effect on the LDL-C, HDL-C, and TC concentrations in individuals with obesity or overweight.
既往研究报道了维生素D与肥胖或超重个体血脂谱之间的关系,但结果并不一致。因此,我们进行了这项随机对照试验的荟萃分析和系统评价,以评估维生素D对超重或肥胖个体血脂谱的影响。
在多个数据库中采用了细致的检索策略,并纳入了截至2023年11月发表的文章。应用DerSimonian和Laird随机效应模型计算干预对每个变量的加权平均差(WMD)和95%置信区间(CI)。
补充维生素D并未使低密度脂蛋白胆固醇(LDL-C)(WMD:2.10mg/dL,CI:-5.20-9.41,p=0.572)、高密度脂蛋白胆固醇(HDL-C)(WMD:1.49mg/dL,95%CI:-1.55-4.55,P=0.337)和总胆固醇(TC)浓度(WMD:-1.99mg/dL,CI:-8.21-4.22,P=0.530)发生显著变化。相反,在患有合并症的个体中进行的研究(WMD:-6.03mg/dL,95%CI:-11.92至-0.15,p=0.044)、维生素D剂量≥50000IU/周(WMD:-20.87mg/dL,95%CI:-39.63至-2.11,P=0.029)以及基线甘油三酯浓度≥150mg/dl的受试者中(WMD:-25.95mg/dL,95%CI:-51.51至-0.40,p=0.046),观察到甘油三酯水平显著降低。
根据我们的研究结果,维生素D对肥胖或超重个体的高甘油三酯血症有显著影响。然而,维生素D对肥胖或超重个体的LDL-C、HDL-C和TC浓度没有显著影响。